Paper Details

Paper Title

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab.

Paper Journal Title

J Neurooncol

Paper Citation Count

Paper Publication Year

2016

Bio Mention

GBM, H-1, N-acetylaspartate, NAA, bevacizumab, choline, creatine, erlotinib, glioblastoma, lactate, patients, temozolomide, tumor

Mesh Descriptor

Author Name	Affiliation
Jason C Crane	University of California san francisco
Annette M Molinaro	University of California san francisco
Annette M Molinaro	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Ritu Roy	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Nicholas Butowski	University of California san francisco
Nicholas Butowski	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Nicholas Butowski	University of California san francisco
Nicholas Butowski	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Michael D Prados	University of California san francisco
Michael D Prados	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Michael D Prados	University of California san francisco
Michael D Prados	Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Soonmee Cha	University of California san francisco

Column Actions